Citadel Advisors »

Unicycive Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $96k 69k 1.38
2023-12-31 $31k 35k 0.87
2022-06-30 $0 15k 0.00
2022-03-31 $48k 37k 1.29

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Unicycive Therapeutics

BVF
RA Capital Management
Vivo Capital
Logos Global Management
Nantahala Capital Management
Rosalind Advisors
Monashee Investment Management
Vanguard Group
Geode Capital Management
Goldman Sachs Group
Citadel Advisors
Northern Trust
Captrust Financial Advisors
Tandem Capital Management Corp
Integrated Wealth Concepts

View all funds holding Unicycive Therapeutics